CR246a : Cervix cancer with normal tissue array, including pathology grade, TNM and clinical stage, 22 cases/24 cores(1.5mm), replacing CR246
|
Microarray Panel | Cervix carcinoma tissue microarray, containing 20 cases adenocarcinoma, 2 cancer adjacent tissue (matched with carcinoma), 2 normal tissue, single core per block | |
Cores | 24 | |
Cases | 22 | |
Row number | 4 | |
Column number | 6 | |
Core Diameter (mm) | 1.5 | |
Thickness (µm) | 5 | |
Quality Control | H&E and IHC confirmed | |
Tissue Array Type | FFPE | |
Species | Human | |
Notes | 1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours. In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers. |
Mouseover and click individual cores to view high resolution images.
Legend: | Cer - Cervix
|
Specification Sheet (Sortable), tissue IDs are available in exported Excel files.
Pos. | No. | Age | Sex | Organ/Anatomic Site | Pathology diagnosis | TNM | Grade | Stage | Type | Image |
---|
A1 | 1 | 48 | F | Cervix | Adenocarcinoma | T1bN0M0 | 1--2 | IB | Malignant | |
A2 | 2 | 44 | F | Cervix | Adenocarcinoma | T1b1N0M0 | 1 | IB1 | Malignant | |
A3 | 3 | 32 | F | Cervix | Adenocarcinoma | T1a1N0M0 | 2 | IA1 | Malignant | |
A4 | 4 | 40 | F | Cervix | Adenocarcinoma | T1b1N0M0 | 2 | IB1 | Malignant | |
A5 | 5 | 64 | F | Cervix | Adenocarcinoma | T1b1N0M0 | 2 | IB1 | Malignant | |
A6 | 6 | 49 | F | Cervix | Adenocarcinoma (sparse) | T1b1N0M0 | 3 | IB1 | Malignant | |
B1 | 7 | 34 | F | Cervix | Adenocarcinoma HPV(++) | T1bN0M0 | 3 | IB | Malignant | |
B2 | 8 | 34 | F | Cervix | Adenocarcinoma | T1b1N0M0 | 3 | IB1 | Malignant | |
B3 | 9 | 40 | F | Cervix | Mucinous carcinoma | T2aN0M0 | 2 | IIA | Malignant | |
B4 | 10 | 40 | F | Cervix | Mucinous carcinoma of cervical canal | T2bN0M0 | 1 | IIB | Malignant | |
B5 | 11 | 41 | F | Cervix | Mucinous carcinoma | T1b1N0M0 | 2 | IB1 | Malignant | |
B6 | 12 | 75 | F | Cervix | Mucinous carcinoma (intestinal type) | T1b1N0M0 | 2 | IB1 | Malignant | |
C1 | 13 | 45 | F | Cervix | Mucinous carcinoma (intestinal type) | T1b1N1M0 | 2 | IB1 | Malignant | |
C2 | 14 | 53 | F | Cervix | Papillary adenocarcinoma (sparse) | T1bN0M0 | 2 | IB | Malignant | |
C3 | 15 | 49 | F | Cervix | Papillary adenocarcinoma | T1a1N0M0 | 2 | IA1 | Malignant | |
C4 | 16 | 45 | F | Cervix | Papillary adenocarcinoma | T1b1N0M0 | 2 | IB1 | Malignant | |
C5 | 17 | 47 | F | Cervix | Endometrioid adenocarcinoma | T1bN0M0 | 2 | IB | Malignant | |
C6 | 18 | 50 | F | Cervix | Clear cell carcinoma | T1a1N0M0 | 2 | IA1 | Malignant | |
D1 | 19 | 48 | F | Cervix | Clear cell carcinoma | T1b2N0M0 | 2 | IB2 | Malignant | |
D2 | 20 | 49 | F | Cervix | High grade serous carcinoma | T2N1M0 | - | IIIB | Malignant | |
D3 | 21 | 32 | F | Cervix | Cancer adjacent cervix tissue of No.3 (chronic cervicitis with erosion) | - | - | - | AT | |
D4 | 22 | 40 | F | Cervix | Cancer adjacent cervix tissue of No.9 (cervical canals tissue) | - | - | - | AT | |
D5 | 23 | 40 | F | Cervix | Cervical canal tissue | - | - | - | Normal | |
D6 | 24 | 27 | F | Cervix | Cervical tissue | - | - | - | Normal | |
- | 0 | 42 | M | Adrenal gland | Pheochromocytoma (tissue marker) | - | Malignant |
Find overlapping cases with this tissue array:
- Product Code: CR246a
- Availability: In Stock